Our mission is to help improve outcomes and reduce complications in as many patients as possible.
The Snapshot Suit includes two powerful imaging devices: SnapshotNIR, a near-infrared tissue oxygenation imaging device initially cleared by the FDA and Health Canada in 2017, and with CE Marking in 2025, and SnapshotGLO, a bacterial autofluorescence imaging device that received FDA 510(k) clearance in 2025.
Together, the Snapshot Suite enhances clinicians’ ability to detect, direct, and protect—promoting consistency of treatment, improving outcomes, and advancing the standard of care for patients worldwide.
Learn more: www.kentimaging.com/
Learn about SnapshotNIR: www.kentimaging.com/snapshotnir
Learn more about SnapshotGLO: www.kentimaging.com/snapshotglo
Shared 1 month ago
1 view
Shared 3 months ago
7 views
Shared 4 months ago
7 views
Shared 4 months ago
7 views
Shared 5 months ago
27 views
Shared 5 months ago
2 views
Shared 5 months ago
10 views
Shared 5 months ago
4 views
Shared 5 months ago
15 views
Shared 5 months ago
9 views
Shared 6 months ago
31 views
Shared 7 months ago
40 views
Shared 7 months ago
107 views
Shared 7 months ago
25 views
Shared 8 months ago
16 views
Shared 9 months ago
21 views
Shared 9 months ago
14 views
Shared 9 months ago
15 views
Harnessing Technology: A Kent Imaging Customer Story with Dr. Navin Gupta of ANP Foot & Ankle Clinic
Shared 9 months ago
119 views
Shared 10 months ago
18 views
Shared 11 months ago
18 views
Shared 1 year ago
17 views
Shared 1 year ago
24 views
Shared 1 year ago
14 views
Shared 1 year ago
21 views
Shared 1 year ago
158 views
Shared 1 year ago
13 views
Shared 1 year ago
128 views
Shared 1 year ago
8 views
Shared 1 year ago
42 views
Shared 1 year ago
9 views
Shared 1 year ago
9 views
Shared 1 year ago
101 views
Shared 1 year ago
11 views
Shared 1 year ago
184 views
Shared 1 year ago
157 views
Shared 1 year ago
59 views
Shared 1 year ago
14 views
Shared 1 year ago
71 views
Shared 1 year ago
60 views
Shared 1 year ago
50 views